Is there a role for ovarian function suppression in operable breast cancer?

By Sparano Joseph  

Breast Cancer Research and Treatment, Vol. 123, Iss. 1, 2010-08 ,pp. : 311-313

Springer Publishing Company

Access to resources Recommend Favorite

Does preoperative MRI improve clinical outcomes in breast cancer?

By Houssami Nehmat   Morrow Monica  

Breast Cancer Management, Vol. 2, Iss. 2, 2013-03 ,pp. : 115-122

Future Medicine

Access to resources Recommend Favorite

Can bone markers guide more effective treatment of bone metastases from breast cancer?

By Clemons Mark   Cole David   Gainford Mary  

Breast Cancer Research and Treatment, Vol. 97, Iss. 1, 2006-05 ,pp. : 81-90

Springer Publishing Company

Access to resources Recommend Favorite

Which is better in neoadjuvant treatment of breast cancer? Taxane followed by anthracyline or vice versa

By Altundag Kadri   Altundag Ozden   Baptista Mauricio   Atik Mustafa  

Breast Cancer Research and Treatment, Vol. 97, Iss. 2, 2006-05 ,pp. : 221-221

Springer Publishing Company

Access to resources Recommend Favorite

Are medical oncologists biased in their treatment of the large woman with breast cancer?

By Madarnas Y.  

Breast Cancer Research and Treatment, Vol. 66, Iss. 2, 2001-03 ,pp. : 123-133

Springer Publishing Company

Access to resources Recommend Favorite